SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001903596-24-000329
Filing Date
2024-05-16
Accepted
2024-05-16 16:32:45
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 kays_10q.htm   iXBRL 10-Q 914904
2 ex31_1.htm EX-31.1 13970
3 ex32_1.htm EX-32.1 4438
9 GRAPHIC image_001.jpg GRAPHIC 4685
10 GRAPHIC image_011.jpg GRAPHIC 17166
11 GRAPHIC image_012.jpg GRAPHIC 5447
12 GRAPHIC image_013.jpg GRAPHIC 16959
13 GRAPHIC image_014.jpg GRAPHIC 63703
14 GRAPHIC image_015.jpg GRAPHIC 13354
15 GRAPHIC image_016.jpg GRAPHIC 4606
16 GRAPHIC image_017.jpg GRAPHIC 41188
17 GRAPHIC image_018.jpg GRAPHIC 36545
  Complete submission text file 0001903596-24-000329.txt   5698154

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE kays-20240331.xsd EX-101.SCH 50024
5 XBRL CALCULATION FILE kays-20240331_cal.xml EX-101.CAL 54526
6 XBRL DEFINITION FILE kays-20240331_def.xml EX-101.DEF 72766
7 XBRL LABEL FILE kays-20240331_lab.xml EX-101.LAB 271150
8 XBRL PRESENTATION FILE kays-20240331_pre.xml EX-101.PRE 201649
77 EXTRACTED XBRL INSTANCE DOCUMENT kays_10q_htm.xml XML 1014490
Mailing Address 915 MIDDLE RIVER DRIVE, SUITE 316 FORT LAUDERDALE FL 33304
Business Address 915 MIDDLE RIVER DRIVE, SUITE 316 FORT LAUDERDALE FL 33304 954-5347895
Kaya Holdings, Inc. (Filer) CIK: 0001530746 (see all company filings)

IRS No.: 900898007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-177532 | Film No.: 24956107
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)